265 related articles for article (PubMed ID: 8781921)
1. Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis.
Almer S; Kald B; Franzén L; Ström M; Tagesson C
Eur J Surg; 1996 May; 162(5):391-6. PubMed ID: 8781921
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
Hocke M; Richter L; Bosseckert H; Eitner K
Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Kp43 (CD 94) receptor by natural killer (NK) cells in ulcerative colitis.
del Mar Cabrera M; Valle J; Pajares JM; Romero I; Zomeño M; Maté J
Hepatogastroenterology; 2001; 48(41):1316-20. PubMed ID: 11677954
[TBL] [Abstract][Full Text] [Related]
5. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
6. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
7. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic and histological patchiness in treated ulcerative colitis.
Kim B; Barnett JL; Kleer CG; Appelman HD
Am J Gastroenterol; 1999 Nov; 94(11):3258-62. PubMed ID: 10566726
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
10. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
11. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis.
Yao K; Yao T; Iwashita A; Matsui T; Kamachi S
Am J Gastroenterol; 2000 Aug; 95(8):1967-73. PubMed ID: 10950044
[TBL] [Abstract][Full Text] [Related]
12. Rectal cell proliferation and colon cancer risk in ulcerative colitis.
Biasco G; Paganelli GM; Miglioli M; Brillanti S; Di Febo G; Gizzi G; Ponz de Leon M; Campieri M; Barbara L
Cancer Res; 1990 Feb; 50(4):1156-9. PubMed ID: 2297764
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
14. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
[TBL] [Abstract][Full Text] [Related]
15. The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
Mawdsley JE; Jenkins DG; Macey MG; Langmead L; Rampton DS
Am J Gastroenterol; 2008 Jun; 103(6):1460-9. PubMed ID: 18510607
[TBL] [Abstract][Full Text] [Related]
16. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of azathioprine in the management of chronic ulcerative colitis.
Rosenberg JL; Wall AJ; Levin B; Binder HJ; Kirsner JB
Gastroenterology; 1975 Jul; 69(1):96-9. PubMed ID: 1097295
[TBL] [Abstract][Full Text] [Related]
18. Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis.
Macfarlane S; Furrie E; Cummings JH; Macfarlane GT
Clin Infect Dis; 2004 Jun; 38(12):1690-9. PubMed ID: 15227614
[TBL] [Abstract][Full Text] [Related]
19. Crypt hyperplasia related to increased lymphocyte activation in the rectal mucosa of children with ulcerative colitis.
Arato A; Savilahti E; Paszti I
Z Gastroenterol; 1994 Sep; 32(9):483-7. PubMed ID: 7801653
[TBL] [Abstract][Full Text] [Related]
20. Nodular duodenitis involving CD8+ cell infiltration in patients with ulcerative colitis.
Honma J; Mitomi H; Murakami K; Igarashi M; Saigenji K; Toyama K
Hepatogastroenterology; 2001; 48(42):1604-10. PubMed ID: 11813583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
